These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8216415)

  • 1. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis.
    Lohmander LS; Neame PJ; Sandy JD
    Arthritis Rheum; 1993 Sep; 36(9):1214-22. PubMed ID: 8216415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain.
    Sandy JD; Flannery CR; Neame PJ; Lohmander LS
    J Clin Invest; 1992 May; 89(5):1512-6. PubMed ID: 1569188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
    Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
    Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
    Sandy JD; Verscharen C
    Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ; Last K; Maciewicz RA
    J Clin Invest; 1996 Nov; 98(10):2292-9. PubMed ID: 8941646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggrecanase cleavage in juvenile idiopathic arthritis patients is minimally detected in the aggrecan interglobular domain but robust at the aggrecan C-terminus.
    Struglics A; Lohmander LS; Last K; Akikusa J; Allen R; Fosang AJ
    Arthritis Rheum; 2012 Dec; 64(12):4151-61; author reply 4162-3. PubMed ID: 22886575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
    Lohmander LS; Ionescu M; Jugessur H; Poole AR
    Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.
    Larsson S; Lohmander LS; Struglics A
    Arthritis Res Ther; 2009; 11(3):R92. PubMed ID: 19545413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of catabolism of aggrecan by articular cartilage.
    Ilic MZ; Handley CJ; Robinson HC; Mok MT
    Arch Biochem Biophys; 1992 Apr; 294(1):115-22. PubMed ID: 1550337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a cleavage-site-specific monoclonal antibody for detecting metalloproteinase-derived aggrecan fragments: detection of fragments in human synovial fluids.
    Fosang AJ; Last K; Gardiner P; Jackson DC; Brown L
    Biochem J; 1995 Aug; 310 ( Pt 1)(Pt 1):337-43. PubMed ID: 7544117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The release of aggrecan fragments into synovial fluid after joint injury and in osteoarthritis.
    Lohmander LS
    J Rheumatol Suppl; 1995 Feb; 43():75-7. PubMed ID: 7752145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid.
    Ilic MZ; Mok MT; Williamson OD; Campbell MA; Hughes CE; Handley CJ
    Arch Biochem Biophys; 1995 Sep; 322(1):22-30. PubMed ID: 7574678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Products resulting from cleavage of the interglobular domain of aggrecan in samples of synovial fluid collected from dogs with early- and late-stage osteoarthritis.
    Innes JF; Little CB; Hughes CE; Caterson B
    Am J Vet Res; 2005 Oct; 66(10):1679-85. PubMed ID: 16273897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.
    Malfait AM; Liu RQ; Ijiri K; Komiya S; Tortorella MD
    J Biol Chem; 2002 Jun; 277(25):22201-8. PubMed ID: 11956193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short-term pharmacodynamic model for monitoring aggrecanase activity: injection of monosodium iodoacetate (MIA) in rats and assessment of aggrecan neoepitope release in synovial fluid using novel ELISAs.
    Swearingen CA; Chambers MG; Lin C; Marimuthu J; Rito CJ; Carter QL; Dotzlaf J; Liu C; Chandrasekhar S; Duffin KL; Mitchell PG; Durham TB; Wiley MR; Thirunavukkarasu K
    Osteoarthritis Cartilage; 2010 Sep; 18(9):1159-66. PubMed ID: 20633676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and characterization of a highly specific and sensitive sandwich ELISA for detection of aggrecanase-generated aggrecan fragments.
    Pratta MA; Su JL; Leesnitzer MA; Struglics A; Larsson S; Lohmander LS; Kumar S
    Osteoarthritis Cartilage; 2006 Jul; 14(7):702-13. PubMed ID: 16549371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpain is involved in C-terminal truncation of human aggrecan.
    Struglics A; Hansson M
    Biochem J; 2010 Sep; 430(3):531-8. PubMed ID: 20618160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage.
    Glant TT; Cs-Szabó G; Nagase H; Jacobs JJ; Mikecz K
    Arthritis Rheum; 1998 Jun; 41(6):1007-18. PubMed ID: 9627010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.